The CCL1-CCR8 signaling axis may contribute to the pathogenesis of HAM/TSP, which might be suggested as a potential therapeutic target for immunotherapy of the disease (Saito et al., 2017). Here, CCR8 is linked to tropical spastic paraparesis.